Clinical Trial Update: Lamictal in the Treatment of Post-Herpetic Neuralgia [Phase 2, Phase 3]

View source ↗

Summary

Lamictal (lamotrigine) in postherpetic neuralgia has a terminated Phase 2/3 trial. The update provides the trial status but no results in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• LAMICTAL (LAMOTRIGINE)

Snippet

Sponsor: George Washington University | Conditions: Neuralgia, Postherpetic | Phase 2, Phase 3 | Status: TERMINATED